Tracheal Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
Esophageal atresia (EA) is a congenital defect of the esophagus involving the interruption of the esophagus with or without connection to the trachea (tracheoesophageal fistula [TEF]).
|
24460849 |
2015 |
Tracheoesophageal Fistula
|
0.020 |
Biomarker
|
disease |
BEFREE |
Esophageal atresia (EA) is a congenital defect of the esophagus involving the interruption of the esophagus with or without connection to the trachea (tracheoesophageal fistula [TEF]).
|
24460849 |
2015 |
Esophageal atresia with or without tracheoesophageal fistula
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Esophageal atresia with or without tracheoesophageal fistula (EA with or without TEF) is one of the neonatal surgical emergencies requiring surgical intervention in the early neonatal period, influencing the developmental outcome in the operated children.
|
30597492 |
2019 |
Esophageal atresia with or without tracheoesophageal fistula
|
0.040 |
Biomarker
|
disease |
BEFREE |
All infants with a diagnosis of EA/TEF made within 30days of life who had surgical repair of their defect defined as esophageal reconstruction with or without ligation of TEF within the first six months of life were included.
|
27993359 |
2017 |
Esophageal atresia with or without tracheoesophageal fistula
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Tracheoesophageal fistula, with or without esophageal atresia (TEF/EA) appears to be a defect of blastogenesis, as is the oculoauriculovertebral (Goldenhar) spectrum (OAVS), with which it has occasionally been associated.
|
7586653 |
1995 |
Esophageal atresia with or without tracheoesophageal fistula
|
0.040 |
Biomarker
|
disease |
BEFREE |
Esophageal atresia with or without tracheoesophageal fistula (EA +/- TEF) usually occurs sporadically either as an isolated malformation or in conjunction with other congenital anomalies.
|
6714984 |
1984 |
Congenital Abnormality
|
0.050 |
Biomarker
|
group |
BEFREE |
Esophageal atresia and tracheoesophageal fistula (EA/TEF) are relatively common malformations in newborns, but the etiology of EA/TEF remains unknown.
|
29621589 |
2018 |
Congenital Abnormality
|
0.050 |
Biomarker
|
group |
BEFREE |
The frequency of each component was: vertebral defects (V), 77 %; anal atresia (A), 62 %; tracheo-esophageal fistula/esophageal atresia (TEF/EA), 58 %; renal anomalies (R), 58 %; limb abnormalities (L), 50 %, and cardiac malformations (C), 42 %.
|
25008186 |
2015 |
Congenital Abnormality
|
0.050 |
Biomarker
|
group |
BEFREE |
The presence of EA/TEF and malformations of the VATER/VACTERL association spectrum in relatives was systematically assessed.
|
24307608 |
2013 |
Congenital Abnormality
|
0.050 |
Biomarker
|
group |
BEFREE |
These findings indicate that intestinal malrotation is more common in infants with EA/TEF than is generally perceived, and that intestinal malrotation in an infant with EA/TEF is associated with a higher burden of additional congenital anomalies, suggesting that this group of infants may have more pervasive developmental deficits and poorer prognosis than has previously been recognized.
|
10471893 |
1999 |
Congenital Abnormality
|
0.050 |
Biomarker
|
group |
BEFREE |
Esophageal atresia with or without tracheoesophageal fistula (EA +/- TEF) usually occurs sporadically either as an isolated malformation or in conjunction with other congenital anomalies.
|
6714984 |
1984 |
Esophageal Atresia
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
In a cohort of 396 infants with esophageal atresia, 20 (5%) had RAA, with 18 having EA with a distal TEF and 2 with pure EA.
|
30224238 |
2019 |
Esophageal Atresia
|
0.070 |
Biomarker
|
disease |
BEFREE |
A male infant with oesophageal atresia and distal tracheo-oesophageal fistula (TEF type C) underwent right thoracotomy and transpleural repair of TEF on day 4 of life.
|
30413439 |
2018 |
Esophageal Atresia
|
0.070 |
Biomarker
|
disease |
BEFREE |
Esophageal atresia and tracheoesophageal fistula (EA/TEF) are relatively common malformations in newborns, but the etiology of EA/TEF remains unknown.
|
29621589 |
2018 |
Esophageal Atresia
|
0.070 |
Biomarker
|
disease |
BEFREE |
This retrospective review of 66 patients with postoperative recurrent and acquired TEF following esophageal atresia repair is the largest such series to date and provides a new categorization for postoperative TEF that helps clarify the diagnostic and therapeutic challenges for management.
|
27616617 |
2017 |
Esophageal Atresia
|
0.070 |
Biomarker
|
disease |
BEFREE |
Esophageal atresia (EA) is a congenital defect of the esophagus involving the interruption of the esophagus with or without connection to the trachea (tracheoesophageal fistula [TEF]).
|
24460849 |
2015 |
Esophageal Atresia
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Second study on the recurrence risk of isolated esophageal atresia with or without trachea-esophageal fistula among first-degree relatives: no evidence for increased risk of recurrence of EA/TEF or for malformations of the VATER/VACTERL association spectrum.
|
24307608 |
2013 |
Esophageal Atresia
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Shared clinical features in this group of patients include microcephaly, prenatal onset growth restriction, heart defects, tracheoesophageal fistula, and esophageal atresia (TEF/EA), skeletal anomalies, and moderate to severe global developmental delay.
|
21271665 |
2011 |
Eczema
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence.
|
29942086 |
2018 |
Vitiligo
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
|
27723757 |
2016 |
Multiple Sclerosis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
|
24076602 |
2013 |
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population.
|
24581835 |
2014 |
Unipolar Depression
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population.
|
24581835 |
2014 |
Major Depressive Disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
Three candidate genes (HOMER1, SLC6A4 and TEF) were chosen for resequencing analysis and association studies as they were reported to be involved in the etiology of MDD and SA.
|
27964944 |
2017 |